Group A and Group C Meningococcal Conjugate Vaccine (Royal Bio-Pharmaceutical)

A群C群脑膜炎球菌多糖结合疫苗（罗益生物制药）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameGroup A and Group C Meningococcal Conjugate Vaccine (Royal Bio-Pharmaceutical)

Drug Alias NameN/A

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Bacterial vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II) +[4]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsMeningitis

Global Approved IndicationsMeningitis

Approved Indications in ChinaMeningitis

Original Approved Country/TerritoryMainland China

Original Approved Date2006/12/20

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaApproved

Originator CompaniesRoyal (Wuxi) Bio-Pharmaceutical Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesRoyal (Wuxi) Bio-Pharmaceutical Co Ltd

Inactive CompaniesN/A

Active IndicationsMeningitis

Inactive IndicationsN/A

Other Information

ATC CodeJ07AH03